Brief: Adalta Says Cell Therapies To Be Preferred Manufacturer Of Cellular Immunotherapies
13/05/2024 24:56
May 13 (Reuters) - Adalta Ltd 1AD.AX :
* CELL THERAPIES TO BE PREFERRED MANUFACTURER OF CELLULAR
IMMUNOTHERAPIES
Source text for Eikon: ID:nASX85WD0c
Further company coverage: 1AD.AX
((Reuters.Briefs@thomsonreuters.com;))